§

Wright Medical Technology, Inc. v. BioMedical Enterprises, Inc.

13385387 (P.T.A.B. May. 26, 2016)
Wright Medical Technology, Inc. v. BioMedical Enterprises, Inc.

16 Cited authorities

  1. Phillips v. AWH Corp.

    415 F.3d 1303 (Fed. Cir. 2005)   Cited 5,813 times   166 Legal Analyses
    Holding that "because extrinsic evidence can help educate the court regarding the field of the invention and can help the court determine what a person of ordinary skill in the art would understand claim terms to mean, it is permissible for the district court in its sound discretion to admit and use such evidence"

  2. Technology v. Videotek

    545 F.3d 1316 (Fed. Cir. 2008)   Cited 247 times   2 Legal Analyses
    Holding that use of term “black box” did not render the claim indefinite because that term was known in the field to represent video standard detector circuitry

  3. Dynamic Drinkware, LLC v. National Graphics, Inc.

    800 F.3d 1375 (Fed. Cir. 2015)   Cited 40 times   18 Legal Analyses
    Stating that once the petitioner meets its initial burden of going forward with evidence that there is anticipating prior art, the patent owner has "the burden of going forward with evidence either that the prior art does not actually anticipate, or . . . that it is not prior art because the asserted claim is entitled to the benefit of a filing date prior to the alleged prior art." (quoting Tech. Licensing Corp. v. Videotek, Inc., 545 F.3d 1316, 1327 (Fed. Cir. 2008))

  4. In re Translogic Technology

    504 F.3d 1249 (Fed. Cir. 2007)   Cited 44 times   2 Legal Analyses
    Recognizing that the Supreme Court set aside the rigid application of the TSM Test and ensured use of customary knowledge as an ingredient in that equation.

  5. In re Thorpe

    777 F.2d 695 (Fed. Cir. 1985)   Cited 40 times   3 Legal Analyses
    Holding that prior art pertinent only to product is proper ground for rejecting product-by-process claims

  6. In re Marosi

    710 F.2d 799 (Fed. Cir. 1983)   Cited 36 times
    Holding claim limitations "are to be interpreted in light of the specification in giving them their 'broadest reasonable interpretation.'"

  7. Biomedical Enters., Inc. v. Solana Surgical, LLC

    CAUSE NO. 1:14-CV-095-LY (W.D. Tex. Nov. 4, 2014)

    CAUSE NO. 1:14-CV-095-LY 11-04-2014 BIOMEDICAL ENTERPRISES, INC., PLAINTIFF, v. SOLANA SURGICAL, LLC, DEFENDANT. LEE YEAKEL UNITED STATES DISTRICT JUDGE MEMORANDUM OPINION AND ORDER REGARDING CLAIMS CONSTRUCTION Before the court are the parties' Joint Claim Construction Statement filed September 10, 2014 (Clerk's Document No. 25); Plaintiff BioMedical Enterprises, Inc. ("BioMedical") and Defendant Solana Surgical, LLC's ("Solana") Opening Claims Construction Briefs filed August 29, 2014 (Clerk's

  8. Johnson Johnson v. W.L. Gore Assoc.

    436 F. Supp. 704 (D. Del. 1977)   Cited 20 times
    In Johnson Johnson v. W.L. Gore Associates, Inc., 436 F. Supp. 704 (D.Del. 1977), the court rejected a laches defense despite some indication the alleged infringement had been occurring for many years prior to the institution of suit.

  9. Application of Fessmann

    489 F.2d 742 (C.C.P.A. 1974)   Cited 7 times

    Patent Appeal No. 9121. January 10, 1974. Edward W. Goldstein, Washington, D.C., attorney of record, for appellant. Joseph F. Nakamura, Washington, D.C., for Commissioner of Patents, Jack E. Armore, Washington, D.C., of counsel. Appeal from the Patent Office Board of Appeals. Before MARKEY, Chief Judge, RICH, LANE and MILLER, Judges, and ALMOND, Senior Judge. ALMOND, Senior Judge. This is an appeal from the decision of the Patent Office Board of Appeals affirming the examiner's rejection, under 35

  10. Application of Pilkington

    411 F.2d 1345 (C.C.P.A. 1969)   Cited 9 times
    Noting that the product itself must be new

  11. Section 102 - Conditions for patentability; novelty

    35 U.S.C. § 102   Cited 5,990 times   998 Legal Analyses
    Prohibiting the grant of a patent to one who "did not himself invent the subject matter sought to be patented"

  12. Section 6 - Patent Trial and Appeal Board

    35 U.S.C. § 6   Cited 186 times   63 Legal Analyses
    Giving the Director authority to designate "at least 3 members of the Patent Trial and Appeal Board" to review "[e]ach appeal, derivation proceeding, post-grant review, and inter partes review"

  13. Section 318 - Decision of the Board

    35 U.S.C. § 318   Cited 161 times   139 Legal Analyses
    Governing the incorporation of claims added via the operation of § 316(d)

  14. Section 42.100 - Procedure; pendency

    37 C.F.R. § 42.100   Cited 192 times   75 Legal Analyses
    Providing that the PTAB gives " claim . . . its broadest reasonable construction in light of the specification of the patent in which it appears"

  15. Section 42.73 - Judgment

    37 C.F.R. § 42.73   Cited 18 times   61 Legal Analyses
    Regarding judgments

  16. Section 90.2 - Notice; service

    37 C.F.R. § 90.2   2 Legal Analyses

    (a)For an appeal under 35 U.S.C. 141 . (1) (i) In all appeals, the notice of appeal required by 35 U.S.C. 142 must be filed with the Director by electronic mail to the email address indicated on the United States Patent and Trademark Office's web page for the Office of the General Counsel. This electronically submitted notice will be accorded a receipt date, which is the date in Eastern Time when the correspondence is received in the Office, regardless of whether that date is a Saturday, Sunday,